Clinical Trials Browser

Phase 3 × Neoplastic Cells, Circulating × Bevacizumab × Clear all

NCT01640405 2019-04-11

VISNU-1

Phase 3 Completed

Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms